What sector does 4D Molecular Therapeutics Inc (FDMT) operate in?
4D Molecular Therapeutics Inc belongs to the Healthcare sector and operates in the Biotechnology industry.
What is 4D Molecular Therapeutics Inc (FDMT) current stock price?
As of the latest data, 4D Molecular Therapeutics Inc stock price is $9.77, with a previous close of $9.66. 4D Molecular Therapeutics Inc gained $0.11 in the last trading session, representing a 1.14% increase.
What is 4D Molecular Therapeutics Inc (FDMT) current market capitalization?
4D Molecular Therapeutics Inc market cap is approximately 498.35 million.
What is 4D Molecular Therapeutics Inc (FDMT) Earnings Per Share (EPS)?
The trailing EPS is -$3.75, and the forward EPS is -$3.48.
What is 4D Molecular Therapeutics Inc (FDMT) EBITDA?
4D Molecular Therapeutics Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -55.62 million.
Does 4D Molecular Therapeutics Inc (FDMT) pay dividends?
No. 4D Molecular Therapeutics Inc does not pay a dividend.
How did 4D Molecular Therapeutics Inc (FDMT) perform in its most recent earnings report?
In the last report (December 31, 2025), 4D Molecular Therapeutics Inc posted an EPS surprise of 0% and a revenue surprise of -77.67%.
When is 4D Molecular Therapeutics Inc (FDMT) next earnings report?
4D Molecular Therapeutics Inc is expected to release its next earnings report on March 31, 2026.
What is 4D Molecular Therapeutics Inc (FDMT) beta (volatility) score?
4D Molecular Therapeutics Inc has a beta of 3.009, indicating very high volatility compared to the market.